Drug details

Liqrev (sildenafil oral suspension)

type of Phosphodiesterase-5 Enzyme Inhibitors

Liqrev (sildenafil) is a phosphodiesterase-5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening.

This drug may have the following side effects:

• headache,
• diarrhea.
• flushing,
• indigestion,
• muscle pain,
• back pain, and
• limb pain,

The following drugs are related to Liqrev, either as a replacement or used together:

• Adcirca (tadalafil tablets)
• Letairis (ambrisentan tablets)
• Tracleer (bosentan)
• Veletri (epoprostenol powder for intravenous administration)
• Flolan (epoprostenol sodium)
• Ventavis (iloprost)
• Remodulin (treprostinil sodium)
• Revatio (sildenafil citrate)
• Tyvaso DPI (treprostinil inhalation powder)
• Tyvaso (treprostinil inhalation solution)